Application in Gene Editing in Ovarian Cancer Therapy.
Luo S, Wang Y, Tao Y, Li S, Wang Z, He W, Wang H, Wang N, Xu J, Song H.
Luo S, et al. Among authors: li s.
Cancer Invest. 2022 Apr;40(4):387-399. doi: 10.1080/07357907.2021.1998521. Epub 2021 Nov 11.
Cancer Invest. 2022.
PMID: 34758691
Review.